| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/HEAD.12649 |
| P698 | PubMed publication ID | 26364805 |
| P50 | author | Stephen D. Silberstein | Q78771344 |
| P2093 | author name string | Hsiangkuo Yuan | |
| P2860 | cites work | Autonomic nervous system and immune system interactions | Q27026889 |
| Vagus nerve stimulation in ischemic stroke: old wine in a new bottle | Q28243638 | ||
| Reflex control of immunity | Q28245909 | ||
| Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents | Q28328378 | ||
| Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin | Q29615449 | ||
| Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology | Q30553148 | ||
| Brain imaging correlates of peripheral nerve stimulation | Q30581093 | ||
| The P3 event-related potential is a biomarker for the efficacy of vagus nerve stimulation in patients with epilepsy | Q30585847 | ||
| Vagus nerve stimulation during rehabilitative training improves functional recovery after intracerebral hemorrhage | Q30587883 | ||
| A review of functional neuroimaging studies of vagus nerve stimulation (VNS). | Q30882380 | ||
| Vagus nerve stimulation suppresses pain but has limited effects on neurogenic inflammation in humans | Q33222367 | ||
| Vagus Nerve Stimulation | Q33595296 | ||
| The vagus nerve and the inflammatory reflex--linking immunity and metabolism | Q33847366 | ||
| Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway | Q33896990 | ||
| Safety and efficacy of vagus nerve stimulation in fibromyalgia: a phase I/II proof of concept trial | Q34027965 | ||
| Correlation between GABA(A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy | Q44568826 | ||
| Via beta-adrenoceptors, stimulation of extrasplenic sympathetic nerve fibers inhibits lipopolysaccharide-induced TNF secretion in perfused rat spleen | Q44673052 | ||
| Effects of vagal stimulation on experimentally induced seizures in rats | Q45021004 | ||
| Neurocardiac responses to vagoafferent electrostimulation in humans. | Q46032115 | ||
| Activation of brain metabolism and fos during limbic seizures: the role of locus coeruleus. | Q46658978 | ||
| Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction | Q46861374 | ||
| A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. | Q46912624 | ||
| Associations between autonomic dysfunction and pain in chemotherapy-induced polyneuropathy | Q46932657 | ||
| Identification and treatment of bronchoconstriction induced by a vagus nerve stimulator employed for management of seizure disorder | Q47864130 | ||
| Comparison of the use of the Valsalva maneuver and the eutectic mixture of local anesthetics (EMLA®) to relieve venipuncture pain: a randomized controlled trial | Q48106880 | ||
| Vagus nerve stimulation attenuates heat- and formalin-induced pain in rats | Q48160345 | ||
| Activation of ascending antinociceptive system by vagal afferent input as revealed in the nucleus ventralis posteromedialis | Q48182363 | ||
| Preemptive effect of nucleus of the solitary tract stimulation on amygdaloid kindling in freely moving cats | Q48437941 | ||
| Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity | Q48579569 | ||
| Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model | Q49072157 | ||
| Neural regulation of inflammation: no neural connection from the vagus to splenic sympathetic neurons. | Q50260435 | ||
| Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. | Q50581052 | ||
| Reflex control of inflammation by sympathetic nerves, not the vagus. | Q50665775 | ||
| Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. | Q50879617 | ||
| Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression. | Q51128684 | ||
| Vagal stomach afferents inhibit somatic pain perception. | Q51551005 | ||
| Preliminary report: modulation of parasympathetic nervous system tone influences oesophageal pain hypersensitivity. | Q51721098 | ||
| Post-training Unilateral Vagal Stimulation Enhances Retention Performance in the Rat | Q52053258 | ||
| Treatment of canine asthma by high selective vagotomy. | Q53066838 | ||
| Tumour necrosis factor-α and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats. | Q54385393 | ||
| Feasibility of Percutaneous Vagus Nerve Stimulation for the Treatment of Acute Asthma Exacerbations | Q57527032 | ||
| Neural aspects of immunomodulation: focus on the vagus nerve | Q34172723 | ||
| Vagal afferent modulation of spinal trigeminal neuronal responses to dural electrical stimulation in rats | Q34288407 | ||
| Sepsis: current dogma and new perspectives | Q34415915 | ||
| The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial | Q34416459 | ||
| α7-cholinergic receptor mediates vagal induction of splenic norepinephrine | Q34872582 | ||
| The parasympathetic nervous system in the quest for stroke therapeutics | Q34997955 | ||
| Methods of assessing vagus nerve activity and reflexes. | Q35067508 | ||
| Targeted lung denervation for moderate to severe COPD: a pilot study | Q35550788 | ||
| Subdiaphragmatic vagal afferent nerves modulate visceral pain | Q35567878 | ||
| Comparison of ΔFosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants. | Q35913161 | ||
| Non-invasive vagus nerve stimulation for the treatment of acute asthma exacerbations-results from an initial case series | Q36752802 | ||
| Low voltage vagal nerve stimulation reduces bronchoconstriction in guinea pigs through catecholamine release | Q37010127 | ||
| Dopamine mediates vagal modulation of the immune system by electroacupuncture. | Q37629454 | ||
| Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response | Q37818749 | ||
| The chemical neuroanatomy of vagus nerve stimulation. | Q37822084 | ||
| Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years. | Q37836162 | ||
| Animal models for vagus nerve stimulation in epilepsy | Q37874739 | ||
| Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation | Q37977474 | ||
| Update on the pathogenesis of complex regional pain syndrome: role of oxidative stress | Q38026523 | ||
| Vagus nerve stimulation for epilepsy: A review of the peripheral mechanisms | Q38028956 | ||
| Vagus nerve stimulation for epilepsy: A review of central mechanisms | Q38066495 | ||
| Non-invasive brain stimulation and the autonomic nervous system | Q38107714 | ||
| The cholinergic anti-inflammatory pathway: a critical review | Q38177419 | ||
| A novel regulator of lung inflammation and immunity: pulmonary parasympathetic inflammatory reflex | Q38179814 | ||
| You may need a nerve to treat pain: the neurobiological rationale for vagal nerve activation in pain management | Q38180868 | ||
| Sympathetic nervous system and inflammation: a conceptual view | Q38187766 | ||
| Changing face of β2-adrenergic and muscarinic receptor therapies in asthma | Q38219715 | ||
| Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling | Q38289394 | ||
| Left vagus nerve stimulation suppresses experimentally induced pain | Q39424945 | ||
| The effect of transcutaneous vagus nerve stimulation on pain perception--an experimental study | Q39614092 | ||
| Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission | Q42495232 | ||
| Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. | Q43240304 | ||
| High-resolution measurement of electrically-evoked vagus nerve activity in the anesthetized dog. | Q43599886 | ||
| Destruction of peripheral C-fibers does not alter subsequent vagus nerve stimulation-induced seizure suppression in rats | Q43622911 | ||
| Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation | Q44233180 | ||
| Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat. | Q44326210 | ||
| A study of inputs to antidromically identified neurons of the locus coeruleus | Q44492696 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 479-490 | |
| P577 | publication date | 2015-09-14 | |
| P1433 | published in | Headache | Q5689497 |
| P1476 | title | Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part III. | |
| P478 | volume | 56 |
| Q60907748 | A unifying conceptual framework of factors associated to cardiac vagal control |
| Q36342509 | Acetylcholine attenuated TNF-α-induced intracellular Ca2+ overload by inhibiting the formation of the NCX1-TRPC3-IP3R1 complex in human umbilical vein endothelial cells |
| Q57816666 | Breath of Life: The Respiratory Vagal Stimulation Model of Contemplative Activity |
| Q30398148 | Can natural ways to stimulate the vagus nerve improve seizure control? |
| Q46121258 | Case report: Percutaneous electrical neural field stimulation in two cases of sympathetically-mediated pain |
| Q93000934 | Contribution of Baroreceptor Function to Pain Perception and Perioperative Outcomes |
| Q89702820 | Do the psychological effects of vagus nerve stimulation partially mediate vagal pain modulation? |
| Q92595313 | Duplicated Vagus Nerve in Adolescence: Case Report and Review of Literature |
| Q55119579 | Effectiveness of transcutaneous electrical nerve stimulation for the treatment of migraine: a meta-analysis of randomized controlled trials. |
| Q64907677 | Effects of Intraoperative Vagal Nerve Stimulation on the Gastrointestinal Microbiome in a Mouse Model of Amyotrophic Lateral Sclerosis. |
| Q49806599 | Effects of vagus nerve stimulation on heart rate variability in children with epilepsy |
| Q40468324 | Electric stimulation of the vagus nerve reduced mouse neuroinflammation induced by lipopolysaccharide. |
| Q47791516 | Extended Long-Term Effects of Cervical Vagal Nerve Stimulation on Headache Intensity/Frequency and Affective/Cognitive Headache Perception in Drug Resistant Complex-Partial Seizure Patients |
| Q51277955 | Influence of Clonidine on Antihypertensive Selective Afferent Vagal Nerve Stimulation in Rats. |
| Q92281327 | Neuromodulation with electromagnetic stimulation for seizure suppression: From electrode to magnetic coil |
| Q39342329 | Neurophysiology and neural engineering: a review |
| Q64240653 | Noninvasive vagus nerve stimulation alters neural response and physiological autonomic tone to noxious thermal challenge |
| Q26748583 | Noninvasive vagus nerve stimulation in the management of cluster headache: clinical evidence and practical experience |
| Q90379413 | Probable Mechanism of Antiepileptic Effect of the Vagus Nerve Stimulation in the Context of the Recent Results in Sleep Research |
| Q47413348 | Proof of concept: short-term non-invasive cervical vagus nerve stimulation in patients with drug-refractory gastroparesis |
| Q47894225 | Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder |
| Q91754351 | Vagus nerve stimulation for primary headache disorders: An anatomical review to explain a clinical phenomenon |
Search more.